Sustained drug-related reaction with eosinophilia and systemic symptoms (DRESS) triggered by low molecular weight heparins in COVID-19: management and precision diagnosis
- PMID: 36090719
- PMCID: PMC9454356
- DOI: 10.5114/ada.2021.109586
Sustained drug-related reaction with eosinophilia and systemic symptoms (DRESS) triggered by low molecular weight heparins in COVID-19: management and precision diagnosis
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Harr T, Scherer K, Tsakiris DA, Bircher AJ. Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractionated heparin and fondaparinux. Allergy 2006; 61: 787-8. - PubMed
-
- Cesana P, Scherer K, Bircher AJ. Immediate type hypersensitivity to heparins: two case reports and a review of the literature. Int Arch Allergy Immunol 2016; 171: 285-9. - PubMed
-
- Porebski G, Gschwend-Zawodniak A, Pichler WJ. In vitro diagnosis of T-cell mediated drug allergy. Clin Exp Allergy 2011; 41: 461-70. - PubMed
LinkOut - more resources
Full Text Sources